Hims & Hers Health, Inc. (HIMS) Income Statement
HIMS 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsHIMS revenue and net income
Where HIMS's revenue goes
2025Each bar shows an amount and its share of revenue. HIMS kept 5.5% of revenue as net income.
HIMS profit margins
HIMS growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +59.0% | +64.5% | +73.6% | — |
| Gross profit | +47.8% | +61.9% | +73.8% | — |
| Operating income | +70.6% | — | — | — |
| Net income | +1.8% | — | — | — |
| EPS (diluted) | +33.7% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
HIMS quarterly EPS vs estimates
Hims & Hers Health beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 9, 2026 (estimate $0.07).
HIMS income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M | $148.8M | $82.6M | $26.7M |
| Cost of revenue | $614.3M | $303.4M | $157.1M | $118.2M | $67.4M | $39.3M | $38.0M | $18.9M |
| Gross profit | $1.73B | $1.17B | $714.9M | $408.7M | $204.5M | $109.5M | $44.6M | $7.8M |
| Research & development | $149.3M | $78.8M | $48.2M | $29.2M | $22.4M | $11.2M | — | — |
| Sales, general & admin | $1.19B | $846.6M | $576.3M | $370.8M | $249.6M | $113.4M | $119.0M | $83.6M |
| Total operating expenses | $1.63B | $1.11B | $744.4M | $477.4M | $319.5M | $124.6M | $119.0M | $83.6M |
| Operating income | $105.6M | $61.9M | −$29.5M | −$68.7M | −$115.0M | −$15.1M | −$74.4M | −$75.8M |
| Interest expense | — | — | — | $3.0M | $3.8M | $10,000 | $369,000 | $0 |
| Income before taxes | $123.9M | $71.7M | −$21.6M | −$65.7M | −$110.8M | −$18.0M | −$72.0M | −$75.2M |
| Income taxes | −$4.4M | −$54.3M | $2.0M | −$31,000 | −$3.1M | $127,000 | $90,000 | $37,000 |
| Net income | $128.4M | $126.0M | −$23.5M | −$65.7M | −$107.7M | −$18.1M | −$72.1M | −$75.2M |
| EBITDA | $178.4M | $88.8M | −$12.1M | −$58.2M | −$106.7M | −$14.1M | −$71.3M | — |
| EPS (diluted) | $1.07 | $0.80 | $0.15 | −$0.32 | −$0.62 | −$0.15 | −$0.46 | −$0.27 |
| Gross margin | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% | 54.0% | 29.2% |
| Operating margin | 4.5% | 4.2% | −3.4% | −13.0% | −42.3% | −10.2% | −90.1% | −284.0% |
| Net margin | 5.5% | 8.5% | −2.7% | −12.5% | −39.6% | −12.2% | −87.3% | −282.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753.2M | $608.1M | $617.8M | $599.0M | $544.8M | $586.0M | $481.1M | $401.6M | $315.6M | $278.2M | $246.6M | $226.7M |
| Cost of revenue | $272.4M | $307.8M | $173.4M | $156.9M | $128.6M | $155.3M | $111.6M | $83.7M | $59.0M | $49.1M | $42.6M | $39.4M |
| Gross profit | $480.8M | $300.3M | $444.4M | $442.1M | $416.2M | $430.7M | $369.5M | $317.9M | $256.6M | $229.1M | $204.1M | $187.3M |
| Research & development | $54.9M | $46.9M | $41.0M | $40.6M | $37.8M | $29.9M | $23.7M | $21.1M | $18.7M | $15.3M | $13.4M | $12.3M |
| Sales, general & admin | $427.6M | $109.7M | $314.2M | $312.8M | $285.1M | $279.8M | $269.1M | $226.9M | $185.5M | $165.1M | $158.2M | $152.0M |
| Total operating expenses | $578.0M | $316.8M | $435.2M | $430.3M | $389.5M | $372.8M | $350.9M | $295.5M | $245.6M | $219.2M | $204.5M | $195.9M |
| Operating income | −$97.2M | −$16.5M | $9.2M | $11.8M | $26.7M | $57.9M | $18.6M | $22.4M | $11.0M | $9.9M | −$400,000 | −$8.6M |
| Interest expense | — | — | — | — | — | — | — | — | — | — | $1.6M | — |
| Income before taxes | −$92.6M | −$101.6M | $18.4M | $12.2M | $32.9M | $60.5M | $22.3M | $23.6M | $13.4M | $12.4M | $2.2M | −$6.9M |
| Income taxes | −$6.3M | −$9.4M | −$2.2M | −$3.6M | −$9.7M | $11.0M | −$3.7M | −$52.0M | $127,000 | $1.3M | $951,000 | $651,000 |
| Net income | −$86.3M | −$92.1M | $20.6M | $15.8M | $42.5M | $49.5M | $26.0M | $75.6M | $13.3M | $11.1M | $1.2M | −$7.6M |
| EBITDA | −$63.2M | −$79.6M | $36.4M | $29.9M | $43.3M | $68.8M | $28.4M | $28.0M | $17.1M | $15.4M | $4.9M | −$4.6M |
| EPS (diluted) | −$0.10 | −$0.19 | $0.22 | $0.28 | $0.29 | $0.28 | $0.11 | $0.43 | $0.16 | $0.10 | $0.01 | $0.06 |
| Gross margin | 63.8% | 49.4% | 71.9% | 73.8% | 76.4% | 73.5% | 76.8% | 79.2% | 81.3% | 82.4% | 82.7% | 82.6% |
| Operating margin | −12.9% | −2.7% | 1.5% | 2.0% | 4.9% | 9.9% | 3.9% | 5.6% | 3.5% | 3.6% | −0.2% | −3.8% |
| Net margin | −11.5% | −15.1% | 3.3% | 2.6% | 7.8% | 8.4% | 5.4% | 18.8% | 4.2% | 4.0% | 0.5% | −3.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HIMS's financial statements (latest annual report filed February 23, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
HIMS financial results
In fiscal year 2025 (ended December 31, 2025), Hims & Hers Health reported revenue of $2.3 billion, up 59.0% from the year before. It had net income of $128.4 million (up 1.8%), a net profit margin of 5.5%. Diluted earnings per share came to $1.07. Over five years revenue grew at an average rate of 73.6% a year.
See the HIMS stock overview for the latest quote and news, or the HIMS chart for price history and technical indicators.
HIMS income statement FAQ
What is Hims & Hers Health's annual revenue?
Hims & Hers Health reported total revenue of $2.3 billion for fiscal year 2025, which ended on December 31, 2025. That was up 59.0% from $1.5 billion the previous year.
Is Hims & Hers Health profitable?
Yes. Hims & Hers Health reported net income of $128.4 million in fiscal 2025, a net profit margin of 5.5%; its operating margin was 4.5%.
What is Hims & Hers Health's gross margin?
Hims & Hers Health's gross margin was 73.8% in fiscal 2025: for every $100 of revenue, Hims & Hers Health kept $74 after the direct cost of its products and services.
How much does Hims & Hers Health spend on research and development?
Hims & Hers Health spent $149.3 million on research and development in fiscal 2025, 6.4% of revenue.
How fast is Hims & Hers Health growing?
Revenue grew 73.6% a year on average over the last five fiscal years, from $148.8 million to $2.3 billion.
What are Hims & Hers Health's earnings per share?
Hims & Hers Health earned $1.07 per diluted share in fiscal 2025, compared with $0.80 a year earlier.
When will Hims & Hers Health report its next earnings?
Hims & Hers Health is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes.
When does Hims & Hers Health's fiscal year end?
Hims & Hers Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 23, 2026.